Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 66Lung Neoplasms 26Small Cell Lung Carcinoma 10Pancreatic Neoplasms 6Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasm Metastasis 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Carcinoma, Pancreatic Ductal 3Adenocarcinoma of Lung 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Prostatic Neoplasms 2NSCLC 2Melanoma 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Tumor Virus Infections 1

Interventions

Carboplatin 18Pemetrexed 10Paclitaxel 6pembrolizumab 5Nivolumab 5Cisplatin 5Gemcitabine 4osimertinib 3entinostat 3camrelizumab 3atezolizumab 3Erlotinib Hydrochloride 3selpercatinib 2pralsetinib 2durvalumab 2apatinib 2Vinorelbine 2Surveys and Questionnaires 2One-Lung Ventilation 2Ipilimumab 2Drug Delivery Systems 2Docetaxel 2Bronchoscopy 2Bevacizumab 2130-nm albumin-bound paclitaxel 2zipalertinib 1zimberelimab 1toripalimab 1taletrectinib 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases × Albumin-Bound Paclitaxel × Thoracic × Clear all
NCT04725448 2021-04-06

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡